(Q40089410)

17 September 2017

1 reference

title

Clinical value of calcium antagonists in treatment of cardiovascular disorders (English)

1 reference

Cardiology and cardiovascular medicine

17 September 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

11 August 2023

author name string

D. M. Krikler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6131086

11 August 2023

E. Rowland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6131086

11 August 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0735109783800357?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

https://api.elsevier.com/content/article/PII:S0735109783800357?httpAccept=text/plain

11 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

Journal of the American College of Cardiology

11 August 2023

published in

1 reference

17 September 2017

volume

1

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

355-364

1 reference

A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

1 reference

7 January 2021

Role of calcium antagonists in cardiovascular therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of lidoflazine on membrane currents and contraction in voltage-clamped frog atrial fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effects of intravenous verapamil on hemodynamics in patients with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of Diltiazem on Electrical and Mechanical Activity of Isolated Cardiac Ventricular Muscle of Guinea Pig

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effects of nifedipine after intravenous and intracoronary administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine in the treatment of prinzmetal's (variant) angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Calcium-Blocker Therapy for Unstable Angina Pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine therapy for refractory coronary arterial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Beneficial Effect of Diltiazem, a New Antianginal Drug, on Angina Pectoris at Rest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine therapy for coronary-artery spasm. Experience in 127 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine blockade of ergonovine-induced coronary arterial spasm: angiographic documentation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Coronary artery spasm during exercise: treatment with verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine in unstable angina: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Double blind evaluation of orally administered iproveratril in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Double-blind Evaluation of Verapamil, Propranolol, and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil versus placebo in relieving stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine therapy for stable angina pectoris: Preliminary results of effects on angina frequency and treadmill exercise response

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil in the treatment of paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Combined therapy with verapamil and propranolol in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Propranolol and threatened myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

A protective effect of verapamil on hypoxic heart muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The effect of -adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increase in resting tension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Comparison of myocardial protection with nifedipine and potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of diltiazem, a calcium antagonist, on myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Myocardial protection through cold cardioplegia with potassium or diltiazem. Experimental evidence that diltiazem provides better protection even when coronary flow is impaired by a critical stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The influence of verapamil on serum digoxin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of verapamil on the noraml action potential and on a calcium-dependent slow response of canine cardiac Purkinje fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Absence of slow channel-dependent conduction within the His-Purkinje (bundle branch) reentrant circuit: A clinical and experimental study of the effects of verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel"

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The natriuretic hormone and essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil in the Management of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The 24-hour ambulatory blood pressure profile with verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Regional wall motion from radiopaque markers after intravenous and intracoronary injections of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Acute hemodynamic effects of nifedipine in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Influence of nifedipine on left ventricular dysfunction at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Primary pulmonary hypertension: effects of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Primary pulmonary hypertension: effects of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Effects of verapamil on myocardial performance in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Adverse interaction between nifedipine and beta-blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine and beta-blockade as a cause of cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine and beta-blocker drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Nifedipine and left ventricular function in beta-blocked patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Production of ischaemic cardiac pain by nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980035-7

7 January 2021

The systemic and coronary hemodynamic effects of iproveratril

18

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease

11 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

FINE STRUCTURAL CHANGES IN MYOCARDIAL ISCHEMIC INJURY

11 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia

11 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia

11 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

Prevention of ventricular fibrillation induced by coronary ligation

11 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

The treatment of hypertension with verapamil

11 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

Effects of verapamil on sinus node function in man

11 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80035-7

11 August 2023

Identifiers

1 reference

17 September 2017

1 reference